AHA 2017Podcasts Effects of Exenatide in Type 2 DM and CVD Sadaf Sharfaei Share 0 Min Read Dr. C. Michael Gibson discusses the trial findings with Dr. Robert Mentz at AHA 2017 TAGGED:AHA 2017Conference Share This Article Copy Link Print Leave a Comment Leave a Reply Cancel replyYou must be logged in to post a comment.
